Your Biopharmaceutical Development and Manufacturing Partner

Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development

Battelle and Nanotherapeutics, Inc. announced today that the organizations have entered an alliance to bring together core research, development, test and evaluation (RDT&E) and manufacturing capabilities needed to expedite the development of medical countermeasures urgently required by the Department of Defense (DoD) to protect deployed military forces from Chemical, Biological, Radiological and Nuclear (CBRN) threats.

Read the Full Article at Global Biodefense

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.